New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
08:08 EDTWXWuXi PharmaTech begins operation of new high-potency API laboratory
WuXi PharmaTech's manufacturing subsidiary, Syn-The-All Pharmaceutical Co., has begun operation of a high-potency active pharmaceutical ingredient laboratory in Shanghai, thereby adding HPAPI processing to its portfolio of services. The lab will support process development and clinical-trial supply of high-potency small molecules at kilogram scale.
News For WX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
08:02 EDTWXWuXi PharmaTech's STA subsidiary receives approval from Japanese authorities
WuXi PharmaTech announced that its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical Co., Ltd. received its first approval from the Japan PMDA for the manufacture of the GMP intermediate of a branded commercial drug in July. STA is now the only Chinese contract manufacturing organization to have received approval to supply active pharmaceutical ingredients and GMP intermediates for branded commercial drugs from regulatory agencies in the United States, Canada, the European Union, Switzerland, China, Japan, Australia, and New Zealand.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use